Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer

被引：0
|
作者：
Fabrice Barlesi
Laure Deyme
Diane-Charlotte Imbs
Elissa Cousin
Mathieu Barbolosi
Sylvanie Bonnet
Pascale Tomasini
Laurent Greillier
Melissa Galloux
Albane Testot-Ferry
Annick Pelletier
Nicolas André
Joseph Ciccolini
Dominique Barbolosi
机构：
[1] Aix Marseille University,Marseille Early Phases Cancer Trials Center CLIP
[2] APHM,SMARTc Unit Centre de Recherche en Cancérologie de Marseille Inserm U1068
[3] Aix Marseille University,Department of Pharmacology Marseille
[4] Gustave Roussy Cancer Campus,undefined
[5] Aix Marseille University,undefined
[6] APHM,undefined
[7] Metronomics Global Health Initiative,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Lung cancer; Mesothelioma; Mathematical modelling; Vinorelbine; Metronomic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：149 / 160
页数：11
相关论文
共 50 条
  • [31] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Camerini, Andrea
    Puccetti, Cheti
    Donati, Sara
    Valsuani, Chiara
    Petrella, Maria Cristina
    Tartarelli, Gianna
    Puccinelli, Paolo
    Amoroso, Domenico
    BMC CANCER, 2015, 15
  • [32] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Preliminary results of a phase II trial (move trial)
    Camerini, A.
    Donati, S.
    Valsuani, C.
    Puccetti, C.
    Petrella, M. C.
    Tartarelli, G.
    Puccinelli, P.
    Amoroso, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S825 - S825
  • [33] Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer
    Masters, GA
    Hahn, EA
    Shevrin, DH
    Kies, MS
    LUNG CANCER, 2003, 39 (02) : 221 - 226
  • [34] Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule
    Elharrar, Xavier
    Barbolosi, Dominique
    Ciccolini, Joseph
    Meille, Christophe
    Faivre, Christian
    Lacarelle, Bruno
    Andre, Nicolas
    Barlesi, Fabrice
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [35] Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
    Tan, Eng Huat
    Tan, Daniel Shao Weng
    Li, Wen Yun
    Haaland, Benjamin
    Ang, Mei Kim
    Chau, Noan Min
    Toh, Chee Keong
    Tan, Lain Bee Huat
    Koh, Tong San
    Thng, Choon Hua
    Chowbay, Balram
    Hui, Kam Man
    Lim, Wan Teck
    Ng, Quan Sing
    LUNG CANCER, 2015, 88 (03) : 289 - 296
  • [36] A computational driven protocol of metronomic oral vinorelbine in metastatic non small cell lung cancer
    Imbs, Diane-Charlotte
    El Cheikh, Raouf
    Ciccolini, Joseph
    Serre, Raphael
    Barlesi, Fabrice
    Barbolosi, Dominique
    CANCER RESEARCH, 2017, 77
  • [37] Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer
    Johnson, E
    Lake, D
    Herndon, JE
    Box, JW
    Lynch, TJ
    Green, MR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 19 - 23
  • [38] PHASE-I STUDY OF VINORELBINE AND CARBOPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER
    JACOULET, P
    BRETON, JL
    WESTEEL, V
    MERCIER, M
    GARNIER, G
    DEPIERRE, A
    LUNG CANCER, 1995, 12 (03) : 247 - 257
  • [39] Phase I study of gemcitabine and vinorelbine in nonsmall cell lung cancer (NSCLC)-elderly patients
    Santomaggio, C
    Portalone, L
    Seebacher, C
    Bazzicalupo, F
    Soresi, E
    ANNALS OF ONCOLOGY, 1998, 9 : 81 - 81
  • [40] Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: Preliminary results of a phase I/II trial
    Miller, VA
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : S15 - S17
12345